Detalles de la búsqueda
1.
The immune cell transcriptome is modulated by vitamin D3 supplementation in people with a first demyelinating event participating in a randomized placebo-controlled trial.
Clin Immunol
; 262: 110183, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38479439
2.
No evidence for association between rs10191329 severity locus and longitudinal disease severity in 1813 relapse-onset multiple sclerosis patients from the MSBase registry.
Mult Scler
; : 13524585241240406, 2024 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38511853
3.
Not all roads lead to the immune system: the genetic basis of multiple sclerosis severity.
Brain
; 146(6): 2316-2331, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36448302
4.
DNA Methylation Signatures of Multiple Sclerosis Occur Independently of Known Genetic Risk and Are Primarily Attributed to B Cells and Monocytes.
Int J Mol Sci
; 24(16)2023 Aug 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37628757
5.
Conceiving complexity: Biological mechanisms underpinning the lasting effect of pregnancy on multiple sclerosis outcomes.
Autoimmun Rev
; 22(9): 103388, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37352902
6.
Parity is associated with long-term differences in DNA methylation at genes related to neural plasticity in multiple sclerosis.
Clin Epigenetics
; 15(1): 20, 2023 02 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36765422
7.
Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis.
Front Immunol
; 14: 1162796, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37325639
8.
Evaluation of Cell-Specific Epigenetic Age Acceleration in People With Multiple Sclerosis.
Neurology
; 101(7): e679-e689, 2023 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37541839
9.
Whole-blood methylation signatures are associated with and accurately classify multiple sclerosis disease severity.
Clin Epigenetics
; 14(1): 194, 2022 12 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36585691
10.
Epigenome-wide association studies: current knowledge, strategies and recommendations.
Clin Epigenetics
; 13(1): 214, 2021 12 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34863305
11.
Patient Preferences for Time and Location of Infusible Therapies in Multiple Sclerosis and Neuroimmunologic Disorders.
Int J MS Care
; 23(3): 114-118, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34177383
12.
The Pharmacogenetics of Rituximab: Potential Implications for Anti-CD20 Therapies in Multiple Sclerosis.
Neurotherapeutics
; 17(4): 1768-1784, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33058021
Resultados
1 -
12
de 12
1
Próxima >
>>